We report one case with chronic postoperative endophthalmitis caused by Roseomonas species. Roseomonas spp. induced chronic endophthalmitis, which might result in misdiagnosis and delayed treatment and causes ocular damage and severe visual loss. This report is the first one related to a case with postoperative endophthalmitis secondary to Roseomonas infection.
isolate was oxidase negative, catalase positive, urease positive, and esculin negative and lacked absorption of long-wave UV light (14) . Results of susceptibility testing using the KirbyBauer disk diffusion technique showed that the isolate was susceptible to amikacin, gentamicin, ciprofloxacin, imipenem, and meropenem; however, it was resistant to aztreonam, ceftazidime, cefepime, piperacillin, and piperacillin-tazobactam. As a result of the isolate's antibiogram, therapy of the right eye was changed to intravitreal amikacin (0.25 mg/0.1 ml) and topical 0.3% ciprofloxacin. One month later, the inflammation had subsided, and light perception was evident; however, the ocular echography showed retinal detachment. Three months later, the right eye was phthisical (bulbar atrophy), with no light perception.
Discussion. The bacterial genus Roseomonas was named in 1993 by Rihs et al. after they studied 42 strains of pink-pigmented, aerobic, slow-growing, gram-negative bacteria (14) . Roseomonas species phenotypically and genotypically resemble Methylobacterium species but are separable from the latter by their inability to oxidize methanol and by their lack of absorption of long-wave UV light. This genus includes 10 named species: Roseomonas aerilata, Roseomonas aquatica, Roseomonas cervicalis, Roseomonas fauriae, Roseomonas gilardii (R. gilardii subsp. gilardii and R. gilardii subsp. rosea), Roseomonas lacus, Roseomonas mucosa, Roseomonas terrae, R. stagni, and R. vinacea.
Since 1993, infections caused by Roseomonas species have been reported in literature (1, 2, 4, 8-10, 13, 16, 17, 19, 20, 21) . These organisms have been isolated from various clinical samples, including blood, urine, wound, catheter, and others.
Nonfermentative gram-negative bacilli, with the exception of Pseudomonas aeruginosa, are typically uncommon etiologic agents of infectious endophthalmitis. Most bacteria could cause acute (less than 2 weeks) and subacute (between 2 and 6 weeks) endophthalmitis; meanwhile, chronic bacterial endophthalmitis (more than 6 weeks) such as that from Propionibacterium acnes infection is not common (3). Chronic bacterial endophthalmitis has been reported to be caused by some species of nonfermentative gram-negative bacilli, including Ochrobactrum anthropi, Achromobacter xylosoxidans, Pseudomonas luteola, Agrobacterium radiobacter, and Pseudomonas oryzihabitans (5, 11, 12, 18, 22, 23) . However, there was no previous report of bacterial endophthalmitis caused by Roseomonas species. Because the isolated Roseomonas sample was not preserved in our case, the Roseomonas sp. isolated was not differentiated into further species.
Antimicrobial susceptibility profiles have been reported, and Roseomonas strains have been reported to be susceptible to amikacin, imipenem, ciprofloxacin, and ticarcillin; however, they are far less susceptible to ceftriaxone, trimethoprimsulfamethoxazole, and ampicillin, and they are essentially not susceptible to ceftazidime or cefepime (6, 8, 14) . Thus, the use of expanded-spectrum cephalosporins (such as ceftazidime, ceftriaxone, and cefepime) to eradicate Roseomonas strains would be a poor choice. Intravitreal injections of antibiotics have become commonly utilized standard treatments for infectious endophthalmitis. The current antibiotic treatment for endophthalmitis includes vancomycin for coverage of grampositive bacteria and either ceftazidime or an aminoglycoside for coverage of gram-negative bacteria (15) . Because of the retinal toxicity of aminoglycosides, most ophthalmologists use ceftazidime instead of aminoglycosides for coverage of gramnegative bacteria. However, before the identification of the organism and the susceptibility test, it is impossible to know which antibiotics can eradicate the organism. As in our case, the Roseomonas isolate was not susceptible to ceftazidime but was susceptible to amikacin. Although pars plana vitrectomy was performed later, intravitreal amikacin and topical ciprofloxacin could not save the vision in the patient's right eye.
Chronic endophthalmitis is frequently misdiagnosed as acute conjunctivitis, uveitis, and glaucoma; therefore, the ophthalmologist should keep in mind the possibility of chronic endophthalmitis caused by unusual organisms, such as Roseomonas species.
In conclusion, we report one case of chronic postoperative endophthalmitis caused by Roseomonas species. Roseomonas infection induces a chronic endophthalmitis which may result in misdiagnosis and delayed treatment and which may cause ocular damage and severe visual loss.
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